Radical and Nitrenoid Reactivity of 3-Halo-3 … SUPPORTING INFORMATION Radical and Nitrenoid...
Transcript of Radical and Nitrenoid Reactivity of 3-Halo-3 … SUPPORTING INFORMATION Radical and Nitrenoid...
S1
SUPPORTING INFORMATION
Radical and Nitrenoid Reactivity of 3-Halo-3-phenyldiazirines
Rafael Navrátil, Ján Tarábek, Igor Linhart and Tomáš Martinů*
TABLE OF CONTENTS
Reactions of diazirines 1a and 3 with organolithiums ****... S2–S6
1H / 13C NMR spectra of compounds 4, 5, 12–14, 16 and 18 *.. S7–S15
IR spectra of compounds 4, 5, 12–14, 16 and 18 ******.. S16–S19
EPR experiment ********************. S20–S22
References ********************..** S23
S2
Preparation of 3-bromo-3-phenyl-3H-diazirine (1a)
Diazirine 1a, a pale yellow liquid, was prepared according to a literature procedure.S1 1H NMR (300 MHz, CDCl3): δ = 7.41-7.35 (m, 3 H), 7.17-7.12 (m, 2 H) ppm. 13C NMR
(75 MHz, CDCl3): δ = 136.7, 129.4, 128.5, 126.6, 38.0 ppm.
Preparation of 3-phenyl-3H-diazirine (3)
Diazirine 3, a colorless liquid, was prepared according to literature procedures.S2 1H NMR (300 MHz, CDCl3): δ = 7.35-7.30 (m, 3 H), 6.95-6.90 (m, 2 H), 2.05 (s, 1 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 136.3, 128.3, 128.0, 125.1, 23.4 ppm.
Reaction of 3-phenyl-3H-diazirine (3) with t-BuLi (standard procedure)
To a solution of t-BuLi (1.7 M in pentane, 2.5 mL, 4.25 mmol) in THF (10 mL) and Et2O
(2.5 mL), cooled to –115 °C (dry ice + ethanol + liquid N2) under argon, was added dropwise
over 20 min a solution of diazirine 3 (100 mg, 0.85 mmol) in THF (1.5 mL). The reaction
mixture was stirred for another 20 min and then it was quenched by the addition of MeOH-d4
(0.3 mL) in THF (0.5 mL) dropwise over 5 min. After warming to room temperature, the
reaction mixture was diluted with H2O (20 mL), extracted with CH2Cl2 (3 × 20 mL), combined
organic layers were washed with H2O (60 mL), dried over Na2SO4 and concentrated under
reduced pressure at 0 °C to afford a yellow liquid, 1-t-butyl-3-phenyldiaziridine (4), essentially
pure by NMR (148 mg, quant. yield). 1H NMR (300 MHz, CDCl3): δ = 7.42-7.31 (m, 5 H), 3.59
(s, 1 H), 1.68 (br s, 1 H), 1.10 (s, 9 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 138.7, 128.6,
128.4, 126.4, 55.7, 52.9, 25.8 ppm. IR (ATR) ν = 3425, 2962, 2926, 2855, 1459, 1361, 1212,
1101, 715 cm-1. HRMS (ESI+) m/z calcd for C11H17N2 [M + H]+ 177.1392, found 177.1385.
Reaction of 3-phenyl-3H-diazirine (3) with LDA/iPr2ND
To a solution of iPr2NH (429 mg, 4.24 mmol) in THF (7.0 mL), cooled to –78 °C under
argon, was added n-BuLi (2.5 M in hexane, 1.7 mL, 4.24 mmol) followed after 30 min of
stirring by MeOH-d4 (70 mg, 2.12 mmol). To the resulting mixture was added dropwise over
6 min a solution of diazirine 3S1 (86 mg, 0.73 mmol) in THF (3.0 mL). The reaction mixture
was stirred for another 60 min and then quenched by the addition of MeOH-d4 (0.2 mL) in
THF (0.5 mL) dropwise over 3 min. After warming to room temperature, the reaction mixture
was diluted with H2O (40 mL), extracted with CH2Cl2 (3 × 20 mL), combined organic layers
were washed with H2O (60 mL), dried over Na2SO4 and concentrated under reduced
S3
pressure at 0 °C to afford a pale yellow liquid (82 mg), a 1:2 mixture of unreacted 3 and
3-phenyldiaziridine (5) (64% yield) by NMR. A sample of pure 5 was obtained by chromato-
graphy on silicagel using hexane-EtOAc (3:2). 1H NMR (300 MHz, CDCl3): δ = 7.39-7.34 (m,
5 H), 4.04 (br s, 1 H), 2.04 (br s, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 137.8, 128.84,
128.78, 125.9, 51.4 ppm. IR (ATR) ν = 3215, 3034, 1457, 1234, 1158, 1061, 851, 761,
697 cm-1. HRMS (ESI+) m/z calcd for C7H9N2 [M + H]+ 121.0766, found 121.0762.
Reaction of 3-bromo-3-phenyl-3H-diazirine (1a) with t-BuLi
The standard procedure with t-BuLi (1.7 M in pentane, 1.8 mL, 3.06 mmol), THF
(8.0 mL), Et2O (2.0 mL), diazirine 1a (200 mg, 1.02 mmol) in THF (1.5 mL) and MeOH
(0.3 mL) in THF (0.5 mL) afforded a pale yellow liquid, tert-butyl(phenyl)ketimine (6)
essentially pure by NMR (153 mg, 93% yield), identical to an authentic sample of 6 prepared
by the the reaction of t-BuLi (2 eq) with PhCN (1 eq) in THF at –78 °C. 1H NMR (300 MHz,
CDCl3): δ = 9.24 (br s, 1 H), 7.36-7.31 (m, 3 H), 7.22-7.17 (m, 2 H), 1.24 (s, 9 H) ppm.
13C NMR (75 MHz, CDCl3): δ = 184.2, 139.5, 127.9, 127.8, 126.3, 40.1, 28.3 ppm. HRMS
(ESI+) m/z calcd for C11H16N [M + H]+ 162.1283, found 162.1276.
Reactions of 3-bromo-3-phenyl-3H-diazirine (1a) with MeLi
A) The standard procedure with MeLi (1.64 M in Et2O, 3.8 mL, 6.23 mmol), THF
(9.0 mL), Et2O (2.5 mL), pentane (2.5 mL), diazirine 1a (400 mg, 2.03 mmol) in THF
(1.0 mL) and MeOH (0.50 mL) in THF (0.5 mL) afforded a yellow-brown liquid (256 mg), a
2.9:1 mixture of unreacted 1a (54% rsm) and benzonitrile (9) (19% yield) by NMR. Nitrile 9
was identical to an authentic sample. 1H NMR (300 MHz, CDCl3): δ = 7.66 (d, J = 7.8 Hz,
2 H), 7.61 (m, 1 H), 7.48 (t, J = 7.5 Hz, 2 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 132.8,
132.1, 129.2, 118.9, 112.4 ppm.
B) The above reaction A performed at –78 °C (instead of –115 °C) afforded an orange
liquid (196 mg), a 1.9:1 mixture of nitrile 9 and methyl(phenyl)ketimine (10), with traces of
acetophenone (total combined yield ca 90%). A similar mixture is produced by the direct
reaction of MeLi (2 eq) with PhCN (1 eq). Ketimine 10: 1H NMR (300 MHz, CDCl3): δ = 8.94
(br s, 1 H), 7.74-7.76 (m, 2 H), 7.42-7.40 (m, 3 H), 2.45 (s, 3 H) ppm. 13C NMR (75 MHz,
CDCl3): δ = 175.1, 138.6, 130.4, 128.4, 126.3, 25.8 ppm. HRMS (ESI+) m/z calcd for C8H10N
[M + H]+ 120.0813, found 120.0809.
C) Optimized conditions for the reduction of 1a to 3: The standard procedure with MeLi
(1.64 M in Et2O, 18.3 mL, 30.0 mmol), THF (26 mL) and pentane (11.5 mL), whereby the
S4
addition of diazirine 1a (65 mg, 0.33 mmol) in THF (3.0 mL) was carried out over the course
of 60 min (syringe pump), followed after another 15 min by quenching with MeOH (2.0 mL) in
THF (2.0 mL), afforded an orange liquid (54 mg), a 1.25:1:2.75 mixture of unreacted 1a
(16.3 mg, 25% rsm), diazirine 3 (7.8 mg, 20% yield) and nitrile 9 (18.7 mg, 55% yield) by 1H
NMR using CH2Br2 as an internal standard. NMR spectra of 1a, 3 and 9 are given above.
Reactions of 3-bromo-3-phenyl-3H-diazirine (1a) with alkylmetals in Et2O afford-
ing N,Nʹ-dialkylbenzamidines 12–14, 16 and 18
NOTE: Due to the hindered rotations of alkyl substituents, their 1H and 13C signals as well as 13C signals of N–C=N and phenyl C1 atoms in NMR spectra of amidines 12, 14, 16 and 18
exhibit broadening, in some cases large enough for the signals to disappear in the base line.
This broadening was partially decreased by taking the NMR spectra at elevated tem-
peratures (323 or 373 K), however, some signals still remained undiscernible. Structure
assignments were also aided by infrared spectroscopy (similarity of bands in the 3400, 1600,
1500 and 700 cm-1 regions for all compounds) as well as by an independent syntheses of
some of the reported compounds.
N,Nʹ-Di-n-butylbenzamidine (12)
The standard procedure with n-BuLi (2.5 M in hexane, 1.3 mL, 3.25 mmol) and Et2O
(6.0 mL) at 0 °C, diazirine 1a (309 mg, 1.57 mmol) in Et2O (3.0 mL) and MeOH (0.30 mL) in
Et2O (0.5 mL) afforded an orange syrup, amidine 12, essentially pure by NMR (285 mg, 78%
yield). The 1H NMR spectrum of 12 corresponds to literature.S3 1H NMR (500 MHz, CDCl3,
323 K): δ = 7.43-7.42 (m, 3 H), 7.29-7.27 (m, 2 H), 3.13 (m(t), 4 H), 1.52 (quint, J = 7.2 Hz,
4 H), 1.33 (sext, J = 7.2 Hz, 4 H), 0.87 (t, J = 7.2 Hz, 6 H) ppm. 1H NMR (500 MHz, DMSO-
d6, 373 K): δ = 7.41-7.36 (m, 3 H), 7.22 (d, J = 6.9 Hz, 2 H), 3.08 (m(t), 4 H), 1.45 (quint, J =
6.7 Hz, 4 H), 1.30 (sext, J = 7.3 Hz, 4 H), 0.85 (t, J = 7.3 Hz, 6 H) ppm. 13C NMR (125 MHz,
CDCl3, 323 K): δ = 129.3, 128.6, 127.5, 33.0, 29.7, 20.2, 13.8 ppm (see the Note above).
13C NMR (125 MHz, DMSO-d6, 373 K): δ = 157.8, 135.3, 127.8, 127.5, 126.9, 32.1, 19.1,
13.0 ppm. IR (ATR) ν = 3262, 2955, 2926, 2858, 1629, 1600, 1497, 1464, 1376, 1299, 1152,
1072, 772, 701 cm-1. HRMS (ESI+) m/z calcd for C15H25N2 [M + H]+ 233.2018, found
233.2010.
S5
N,Nʹ-Dimethylbenzamidine (13)
The standard procedure with MeLi (1.64 M in Et2O, 12.2 mL, 20.0 mmol) and Et2O
(24 mL) at –110 °C, whereby the addition of diazirine 1a (197 mg, 1.00 mmol) in Et2O
(4.0 mL) was carried out over the course of 60 min (syringe pump), followed after another
15 min by quenching with and MeOH (2.0 mL) in Et2O (2.0 mL), afforded a yellow syrup
(132 mg), with amidine 13 as its major constituent (79 mg, 53% yield) by 1H NMR using
CH2Br2 as an internal standard. A sample of pure 13 was obtained by crystallization from
Et2O as a white solid (m.p. = 79-80 °C). 1H NMR (300 MHz, CDCl3): δ = 7.41-7.39 (m, 3 H),
7.29-7.25 (m, 2 H), 3.16 (br s, 1 H), 2.89 (s, 6 H) ppm. 13C NMR (75 MHz, CDCl3): δ = 161.1,
135.4, 128.9, 128.5, 127.5, 26.3 ppm. IR (ATR) ν = 3228, 3057, 2938, 2867, 1628, 1600,
1529, 1404, 1331, 1032, 773, 702 cm-1. HRMS (ESI+) m/z calcd for C9H13N2 [M + H]+
149.1079, found 149.1072.
N,Nʹ-Di-tert-butyl- (14) and N-tert-butylbenzamidine (15)
The standard procedure with t-BuLi (1.7 M in pentane, 2.8 mL, 4.76 mmol) and Et2O
(33 mL) at –110 °C, whereby the addition of diazirine 1a (190 mg, 0.96 mmol) in Et2O
(4.0 mL) was carried out over the course of 60 min (syringe pump), followed after another
15 min by quenching with MeOH (1.0 mL) in Et2O (1.0 mL), afforded a dark yellow syrup
(118 mg). Separation by preparative TLC on silicagel using hexane-EtOAc (1:1) with 1% of
Et3N afforded purified 14 (Rf ~ 0.07) and 15 (Rf ~ 0.01) as colorless films. The structures
were confirmed by comparison to authentic samples obtained by an independent
synthesis.S4,S5 Subsequent 1H NMR analysis using CH2Br2 as an internal standard indicated
the abundance of 14 (45 mg, 20% yield) and 15 (25 mg, 15% yield) in the crude product.
14: 1H NMR (500 MHz, CDCl3, 323 K): δ = 7.59-7.26 (m, 5H), 1.17 (br s, 18 H) ppm.
13C NMR (125 MHz, CDCl3, 323 K): δ = 128.0 (br), 31.0 (br) ppm (see the Note on page S4).
IR (ATR) ν = 3436, 3232, 2970, 1615, 1476, 1447, 1404, 1371, 1193, 1101, 792, 713 cm-1.
HRMS (ESI+) m/z calcd for C15H25N2 [M + H]+ 233.2018, found 233.2012.
15: 1H NMR (300 MHz, CDCl3): δ = 7.50-7.47 (m, 2 H), 7.39-7.35 (m, 3 H), 6.29 (br s,
1 H), 4.52 (br s, 1 H), 1.48 (s, 9H) ppm. 13C NMR (75 MHz, CDCl3): δ = 164.3, 140.2, 129.5,
128.6, 125.8, 51.3, 28.8 ppm. HRMS (ESI+) m/z calcd for C11H17N2 [M + H]+ 177.1392, found
177.1385.
S6
N,Nʹ-Di-isopropylbenzamidine (16)
The standard procedure with iPrMgCl.LiCl (1.23 M in THF, 6.2 mL, 7.66 mmol) and
THF (5.0 mL) at –78 °C, whereby the addition of diazirine 1a (503 mg, 2.55 mmol) in THF
(5.0 mL) was carried out over the course of 40 min (syringe pump), followed after another
80 min by quenching with MeOH (2.0 mL) in THF (2.0 mL), afforded a yellow syrup, amidine
16, essentially pure by NMR (341 mg, 65% yield). A sample of analytically pure 16, a white
semisolid, was obtained by room temperature vacuum transfer (5 × 10-2 Torr) into a –196 °C
U-trap followed by preparative TLC on silicagel using hexane-EtOAc (1:1) with 1% of Et3N
(Rf ~ 0.10). 1H NMR (500 MHz, DMSO-d6, 373 K): δ = 7.47 (br s, 3 H), 7.31 (br s, 2 H), 3.60
(br s, 2 H), 1.09 (d, J = 5.2 Hz, 12 H) ppm. 13C NMR (125 MHz, DMSO-d6, 373 K): δ = 157.5,
133.3, 128.8, 127.9, 126.8, 45.1 (br), 22.6 ppm. IR (ATR) ν = 3432, 3210, 2964, 2929, 2871,
2739, 1632, 1600, 1485, 1467, 1446, 1402, 1371, 1333, 1130, 1099, 782, 771, 704 cm-1.
HRMS (ESI+) m/z calcd for C13H21N2 [M + H]+ 205.1705, found 205.1700.
N-Methyl-Nʹ-(2-oxolanyl)benzamidine (18)
To a solution of anhydrous ZnBr2 (3.24 g, 14.4 mmol) in THF (26 mL), cooled to –10 °C
under argon, was added MeLi (1.64 M in Et2O, 26.3 mL, 43.1 mmol). The mixture was stirred
for 30 min and then it was cooled to –78 °C. To this solution of Me3ZnLiS6 was added
dropwise over 80 min (syringe pump) a solution of diazirine 1a (772 mg, 3.92 mmol) in THF
(12 mL). The reaction mixture was stirred for another 40 min and then it was quenched by
the addition of MeOH (4.0 mL) in THF (4.0 mL). After warming to room temperature, the
reaction mixture was diluted with H2O (100 mL), extracted with CH2Cl2 (3 × 100 mL),
combined organic layers were washed with H2O (250 mL), dried over Na2SO4 and
concentrated under reduced pressure to afford a yellowish syrup (594 mg), containing
amidines 13 (244 mg, 42% yield) and 18 (320 mg, 40% yield) by 1H NMR using CH2Br2 as an
internal standard. Purified 18 was obtained as a yellowish syrup by preparative TLC on
silicagel using CH2Cl2-MeOH (9:1) with 1% of Et3N (Rf ~ 0.18). NMR spectra of 13 are given
above. 18: 1H NMR (500 MHz, CDCl3, 323 K): δ = 7.41 (br s, 3 H), 7.36-7.34 (m, 2 H), 5.06
(br m, 1 H), 4.05-4.02 (m, 1 H), 3.75-3.73 (m, 1 H), 2.88 (s, 3 H), 2.11-2.05 (m, 1 H), 1.96 (br
s, 1 H), 1.82 (br s, 2 H) ppm. 13C NMR (125 MHz, CDCl3, 323 K): δ = 161.1, 135.0, 129.2,
128.3, 127.5, 91.1, 67.1, 33.9, 28.5, 25.6 ppm. IR (ATR) ν = 3326, 3058, 2942, 2870, 1613,
1597, 1573, 1526, 1444, 1412, 1319, 1201, 1159, 1043, 922, 772, 702 cm-1. HRMS (ESI+)
m/z calcd for C12H17N2O [M + H]+ 205.1341, found 205.1335.
S7
Figure S1. 1H NMR (300 MHz, CDCl3) spectrum of diaziridine 4
Figure S2. 13C NMR (75 MHz, CDCl3) spectrum of diaziridine 4
N NH
HPh
4t-Bu
N NH
HPh
4t-Bu
S8
Figure S3. 1H NMR (300 MHz, CDCl3) spectrum of diaziridine 5
Figure S4. 13C NMR (75 MHz, CDCl3) spectrum of diaziridine 5
HN NH
HPh
5
HN NH
HPh
5
S9
Figure S5. 1H NMR (500 MHz, CDCl3, 323 K) spectrum of amidine 12
Figure S6. 1H NMR (500 MHz, DMSO-d6, 373 K) spectrum of amidine 12
NHn-BuPh
Nn-Bu
12
NHn-BuPh
Nn-Bu
12
S10
Figure S7. 13C APT NMR (125 MHz, CDCl3, 323 K) spectrum of amidine 12
Figure S8. 13C APT NMR (125 MHz, DMSO-d6, 373 K) spectrum of amidine 12
NHn-BuPh
Nn-Bu
12
NHn-BuPh
Nn-Bu
12
S11
Figure S9. 1H NMR (300 MHz, CDCl3) spectrum of amidine 13
Figure S10. 13C NMR (75 MHz, CDCl3) spectrum of amidine 13
NHMePh
NMe
13
NHMePh
NMe
13
S12
Figure S11. 1H NMR (500 MHz, CDCl3, 323 K) spectrum of amidine 14
Figure S12. 13C APT NMR (125 MHz, CDCl3, 323 K) spectrum of amidine 14
NHt-BuPh
Nt-Bu
14
NHt-BuPh
Nt-Bu
14
S13
Figure S13. 1H NMR (500 MHz, DMSO-d6, 373 K) spectrum of amidine 16
Figure S14. 13C APT NMR (125 MHz, DMSO-d6, 373 K) spectrum of amidine 16
NHiPrPh
NiPr
16
NHiPrPh
NiPr
16
S14
Figure S15. 1H NMR (500 MHz, CDCl3, 323 K) spectrum of amidine 18
Figure S16. 13C APT NMR (125 MHz, CDCl3, 323 K) spectrum of amidine 18
HNPh
NMe
O
18
HNPh
NMe
O
18
S16
Figure S18. IR (ATR) spectrum of diaziridine 4
Figure S19. IR (ATR) spectrum of diaziridine 5
N NH
HPh
4t-Bu
HN NH
HPh
5
S17
Figure S20. IR (ATR) spectrum of amidine 12
Figure S21. IR (ATR) spectrum of amidine 13
NHn-BuPh
Nn-Bu
12
NHMePh
NMe
13
S18
Figure S22. IR (ATR) spectrum of amidine 14
Figure S23. IR (ATR) spectrum of amidine 16
NHt-BuPh
Nt-Bu
14
NHiPrPh
NiPr
16
S20
EPR Experiment
The EPR experiment was performed on EMXplus-10/12 CW (continuous wave)
spectrometer (Bruker, Germany) equipped with the Premium-X band microwave bridge. The
EPR spectrum of the 3-phenyldiazirinyl radical (7) was recorded in special dielectric mixing
cell cavity (ER4117DMX, Bruker) enabling the detection of transient radicals generated in a
continuous-flow system. For this purpose two Hamilton syringes were filled with solutions of
diazirine 1a (8.5 × 10–2 M) and MeLi (5.1 × 10–1 M) in THF. Afterwards, they were connected
by the Luer-lock system with teflon tubes coming to mixing cell cavity. The sampling of both
reactants was performed by dual syringe-pump (kdScientific, US), which was positioned
outside of the EPR magnet. The sampling flow was kept constant at 2 × 10–2 mL.min–1. When
both reactant solutions reached the cavity, the recording of EPR spectrum (accumulation of
70 sweeps) was started and recording continued in situ during the whole mixing time of both
reactants (ca. 60 min). The EPR spectrum-sweeps were recorded using the following experi-
mental parameters: sweep width = 60 mT, modulation amplitude = 1.0 × 10–1 mT, resolution
= 3.0 × 10–2 mT, modulation frequency = 100 kHz, time constant = 10.2 ms, conversion time
= 24 ms, receiver gain = 1 × 105, microwave power = 8.0 × 10–1 mW. The g-factor was
determined using a built-in spectrometer frequency counter and an ER 036TM NMR-Tesla-
meter (both Bruker, Germany).
Theoretical calculations and EPR simulations
All calculations have been carried out within the Gaussian 09/Revision D.01 package.S7
The geometry optimization of radical 7 in THF was performed by the hybrid functional
B3LYPS8 with the triple-ζ 6-311+G(d,p) basis set. Afterwards, the harmonic vibrational
analysis confirmed the potential energy minimum of the geometry. The EPR hyperfine
coupling (A) / splitting (a) constants (HFCCs/HFSCs) as well as the g-factor and the spin
density were calculated by B3LYP using the triple-ζ basis sets: EPR-III for all atoms.S9 All
computations for the open-shell diazirine radical were performed in unrestricted fashion (i.e.
by UB3LYP) and the resulting spin contamination, after the geometry- or single-point energy
calculation, was small and the eigenvalue of Ŝ2 did not exceed 0.777.
Solvent (THF) effects in all calculations were incorporated by the self-consistent
reaction field theory at the level of conductor-like polarizable continuum model CPCM.S10 The
equilibrium geometry and spin density of the radical were visualized by VMD software
package.S11
S21
Simulations of EPR spectra were done within the EasySpin 5.0.20 packageS12 and
treated by the Origin data analysis software (OriginLab, Northhampton, MA). Experimental
parameters such as modulation amplitude, central field, sweep width, microwave frequency
and the spectral resolution (number of points) were included in the simulation.
Figure S25. Spin density (iso value = 0.0024 e/Å3) of radical 7 calculated at the B3LYP/
EPR-III//B3LYP/6-311+G(d,p)/CPCM(THF) level. Blue surfaces: positive values (alpha
spins), red surfaces: negative values (beta spins).
Table S1. DFT calculated EPR parameters compared to those obtained by EPR spectrum
simulation. A (MHz)/a (mT): hyperfine coupling/splitting constants (those for 13C nuclei are
not presented) and g-factors.
A/a (14N1,14N2) A/a (1H10,1H14) A/a (1H11,1H13) A/a (1H12) g
DFT 21.40 / 0.764 1.92 / 0.069 –0.94 / –0.034 1.93 / 0.069 2.0043
simul. 21.00 / 0.749 2.00 / 0.071 –1.00 / –0.036 2.00 / 0.071 2.0039
S22
Table S2. Geometry of radical 7 calculated at the B3LYP/6-311+G(d,p)/CPCM(THF) level.
--------------------------------------------------------------
coordinates (Ångstroms)
atom X Y Z
--------------------------------------------------------------
N1 15.363248 -15.847203 -0.454507
N2 15.975553 -17.202794 -0.063869
C3 16.644663 -16.107221 -0.338193
C4 17.964590 -15.541984 -0.445066
C5 19.086577 -16.343578 -0.187066
C6 20.358339 -15.793636 -0.291498
C7 20.509439 -14.452319 -0.651089
C8 19.392288 -13.654049 -0.908005
C9 18.116443 -14.194952 -0.806186
H10 18.953867 -17.382410 0.090874
H11 21.230420 -16.404996 -0.094150
H12 21.503079 -14.026856 -0.731532
H13 19.519166 -12.614951 -1.186228
H14 17.240627 -13.587952 -1.002483
--------------------------------------------------------------
S23
References
S1. Moss, R. A.; Terpinski, J.; Cox, D. P.; Denney, D. Z.; Krogh-Jespersen, K. J. Am.
Chem. Soc. 1985, 107, 2743.
S2. (a) Smith, R. A. G.; Knowles, J. R. J. Chem. Soc., Perkin Trans. 2 1975, 7, 686.
(b) Likhotvorik, I. R.; Tae, E. L.; Ventre, C.; Platz, M. S. Tetrahedron Lett. 2000, 41,
795.
S3. Biswas, D.; Hrabie, J. A.; Saavedra, J. E.; Cao, Z.; Keefer, L. K.; Ivanic, J.; Holland, R.
J. J. Org. Chem. 2014, 79, 4512.
S4. So, C.-W.; Roesky, H. W.; Magull, J.; Oswald, R. B. Angew. Chem. Int. Ed. 2006, 45,
3948.
S5. Clement, B.; Immel, M. Arch. Pharm. 1987, 320, 660.
S6. Organozinc Reagents: A Practical Approach; Knochel, P.; Jones, P., Eds.; Oxford
University Press: New York, NY, 1999.
S7. Gaussian 09 (Revision D.01), Frisch, M. J.; Trucks, G. W.; Schlegel, H. B.; Scuseria,
G. E.; Robb, M. A.; Cheeseman, J. R.; Scalmani, G.; Barone, V.; Mennucci, B.;
Petersson, G. A. et al., Gaussian, Inc., Wallingford CT, 2009.
S8. Becke, A. D. J. Chem. Phys. 1993, 98, 5648.
S9. Recent Advances in Density Functional Methods, Part I, 1st ed.; Chong, D. P., Ed.;
World Scientific Publ. Co.: Singapore, 1996.
S10. (a) Barone, V.; Cossi, M. J. Phys. Chem. A 1998, 102, 1995. (b) Cossi, M.; Rega, N.;
Scalmani, G.; Barone, V. J. Comp. Chem. 2003, 24, 669.
S11. (a) Humphrey, W.; Dalke, A.; Schulten, K. J. Mol. Graphics 1996, 14, 33. (b) 2015;
http://www.ks.uiuc.edu/Research/vmd.
S12. (a) Stoll, S.; Schweiger, A. J. Magn. Reson. 2006, 178, 42. (b) 2016;
http://www.easyspin.org.